featured
Effects of SGLT2 Inhibitors on Cardiovascular and Renal Outcomes in People With Diabetes and Advanced Chronic Kidney Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetologia
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effects of sodium-glucose cotransporter 2 inhibitors on cardiovascular and renal outcomes in people with diabetes and advanced chronic kidney disease
Diabetologia 2024 Nov 01;67(11)2459-2470, DS Lin, JK Lee, KC Huang, TT Lin, HY LoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.